NO862321L - Fysiologisk middel for oekning av transdermal avlevering av legemidler. - Google Patents
Fysiologisk middel for oekning av transdermal avlevering av legemidler.Info
- Publication number
- NO862321L NO862321L NO862321A NO862321A NO862321L NO 862321 L NO862321 L NO 862321L NO 862321 A NO862321 A NO 862321A NO 862321 A NO862321 A NO 862321A NO 862321 L NO862321 L NO 862321L
- Authority
- NO
- Norway
- Prior art keywords
- delivery system
- transdermal delivery
- area
- agent
- delivery
- Prior art date
Links
- 230000037317 transdermal delivery Effects 0.000 title abstract 5
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000001262 anti-secretory effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical group 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000005068 transpiration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65991984A | 1984-10-11 | 1984-10-11 | |
| PCT/US1985/001951 WO1986002272A1 (en) | 1984-10-11 | 1985-10-09 | Physiological means of enhancing transdermal delivery of drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO862321D0 NO862321D0 (no) | 1986-06-10 |
| NO862321L true NO862321L (no) | 1986-08-07 |
Family
ID=24647370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862321A NO862321L (no) | 1984-10-11 | 1986-06-10 | Fysiologisk middel for oekning av transdermal avlevering av legemidler. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0198034B1 (enExample) |
| JP (1) | JPS62500523A (enExample) |
| KR (1) | KR930009787B1 (enExample) |
| AU (1) | AU592322B2 (enExample) |
| CA (1) | CA1264033A (enExample) |
| DE (1) | DE3583234D1 (enExample) |
| DK (1) | DK269986A (enExample) |
| FI (1) | FI862493A7 (enExample) |
| GR (1) | GR852469B (enExample) |
| IE (1) | IE59291B1 (enExample) |
| IL (1) | IL76635A0 (enExample) |
| MY (1) | MY100471A (enExample) |
| NO (1) | NO862321L (enExample) |
| NZ (1) | NZ213753A (enExample) |
| WO (1) | WO1986002272A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1705319A1 (ru) * | 1987-10-23 | 1992-01-15 | Всесоюзный Научно-Исследовательский Институт Биотехнологии | Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ |
| US6395757B1 (en) * | 1998-08-31 | 2002-05-28 | Arthur M. Bobrove | Method for treating hot flashes in humans |
| AU2002340058A1 (en) * | 2001-09-26 | 2003-04-07 | Alison B. Lukacsko | Compositions and methods for inhibiting eccrine perspiration in humans |
| EP1835812B1 (de) * | 2004-12-27 | 2011-08-17 | Beiersdorf AG | Glycopyrrolat in kosmetischen zubereitungen |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| ES2699257T3 (es) | 2013-02-28 | 2019-02-08 | Dermira Inc | Sales de glicopirrolato |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US376886A (en) * | 1888-01-24 | Joseph beeakley holder | ||
| US3767786A (en) * | 1961-04-20 | 1973-10-23 | Procter & Gamble | Inhibiting perspiration with scopolamine esters |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| NL8104929A (nl) * | 1980-11-12 | 1982-06-01 | Alza Corp | Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. |
| US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
-
1985
- 1985-10-09 NZ NZ213753A patent/NZ213753A/xx unknown
- 1985-10-09 JP JP60504771A patent/JPS62500523A/ja active Pending
- 1985-10-09 KR KR1019860700351A patent/KR930009787B1/ko not_active Expired - Fee Related
- 1985-10-09 EP EP85905267A patent/EP0198034B1/en not_active Expired - Lifetime
- 1985-10-09 WO PCT/US1985/001951 patent/WO1986002272A1/en not_active Ceased
- 1985-10-09 DE DE8585905267T patent/DE3583234D1/de not_active Expired - Lifetime
- 1985-10-09 IL IL76635A patent/IL76635A0/xx not_active IP Right Cessation
- 1985-10-09 AU AU49685/85A patent/AU592322B2/en not_active Ceased
- 1985-10-10 IE IE249185A patent/IE59291B1/en not_active IP Right Cessation
- 1985-10-10 CA CA000492685A patent/CA1264033A/en not_active Expired
- 1985-10-11 GR GR852469A patent/GR852469B/el unknown
-
1986
- 1986-06-09 DK DK269986A patent/DK269986A/da not_active Application Discontinuation
- 1986-06-10 NO NO862321A patent/NO862321L/no unknown
- 1986-06-11 FI FI862493A patent/FI862493A7/fi not_active Application Discontinuation
-
1987
- 1987-09-22 MY MYPI87001837A patent/MY100471A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK269986A (da) | 1986-08-11 |
| KR930009787B1 (ko) | 1993-10-11 |
| MY100471A (en) | 1990-10-15 |
| JPS62500523A (ja) | 1987-03-05 |
| IE852491L (en) | 1986-04-11 |
| IE59291B1 (en) | 1994-02-09 |
| WO1986002272A1 (en) | 1986-04-24 |
| AU592322B2 (en) | 1990-01-11 |
| EP0198034A1 (en) | 1986-10-22 |
| GR852469B (enExample) | 1986-02-12 |
| NO862321D0 (no) | 1986-06-10 |
| DK269986D0 (da) | 1986-06-09 |
| IL76635A0 (en) | 1986-02-28 |
| NZ213753A (en) | 1988-09-29 |
| FI862493A0 (fi) | 1986-06-11 |
| DE3583234D1 (de) | 1991-07-18 |
| FI862493A7 (fi) | 1986-06-11 |
| EP0198034B1 (en) | 1991-06-12 |
| KR870700364A (ko) | 1987-12-28 |
| CA1264033A (en) | 1989-12-27 |
| AU4968585A (en) | 1986-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
| MY102378A (en) | Transdermal delivery system. | |
| ES2067546T3 (es) | Derivado de oxaspiro(2,5)octano. | |
| PL326497A1 (en) | Pharmaceutic preparation for trancutaneous administration of active substances | |
| NL1003273A1 (nl) | Inrichting voor transdermale afgifte van fentanyl en sufentanil door middel van elektrotransport. | |
| AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
| IE46069L (en) | Adhesive skin patch | |
| WO2000074661A3 (en) | Solubility enhancement of drugs in transdermal drug delivery systems and methods of use | |
| EP0879601A3 (en) | Ophthalmic drug delivery system | |
| DK581685D0 (da) | Transderimalt system for timolol-indgift | |
| EP1118325A3 (en) | Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis | |
| YU48607B (sh) | Transdermalni terapeutski sistem (tts) za odavanje galantamina | |
| DK0904067T3 (da) | Transdermalt indgivet dextromethorpan som hostestillende middel | |
| GB2256367B (en) | Transdermal administration of salts of medetomidine | |
| Grandt et al. | Evidence for two GTPases activated by thrombin in membranes of human platelets | |
| NO922475D0 (no) | Imidazolforbindelser, fremgangsmaate for fremstilling derav samt anvendelse derav for fremstilling av farmasoeytiske preparater | |
| EP1413299A3 (en) | Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function | |
| DK0825865T3 (da) | Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat | |
| MY100471A (en) | Physiological means of enhancing transdermal delivery of drugs | |
| Simmonds et al. | Transdermal fentanyl: long-term analgesic studies | |
| Illes et al. | Presynaptic opioid receptors in the rabbit ear artery | |
| EP0175440A3 (en) | Method of treating migraine headaches | |
| FI911269A0 (fi) | Foerfarande och komposition foer foerhoejd hudkoncentration av aktiva medel medelst jontofores. | |
| Contreras et al. | Decrease of tolerance development to morphine by 5-hydroxytryptophan and some related drugs | |
| Parker et al. | Withdrawal syndromes following cessation of treatment with antihypertensive drugs |